Trial intelligence / Profile preview

Effects of Plasmapheresis on Mycophenolic Acid Concentrations in Kidney Transplant Patients

TCTR20190211001Completed

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of mycophenolic acid in Kidney allograft status (RTx), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Change in mycophenolic acid concentration with plasmapheresis. Started Jan 2018; status: completed.

02

Drugs

mycophenolic acid
03

Conditions

Kidney allograft status (RTx)

Beyond the preview

Go deeper on TCTR20190211001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190211001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call